BSE filing, BSE: 531686. Summary written from the filing by ALFA Finder's alert engine.
Advik Laboratories Ltd: key numbers
- Share price
- ₹2.08
- Market cap
- ₹3.98 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.02 Cr
- P/E (TTM)
- -3.8×Sector 46.1×
- Promoter holding
- 35.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advik Laboratories Ltd
All →Advik Laboratories Other Announcement
MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.
MPS Pharma Management Change
MPS Pharmaa Limited announced the appointment of Anchal Goyal as an Independent Director for a five-year term. The company also re-appointed Ram Niwas Sharma and statutory auditors Nemani Garg Agarwal & Co.
Advik Laboratories Annual General Meeting
MPS Pharmaa Limited held its 32nd Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of audited financial statements and director appointments.
Advik Laboratories Annual General Meeting
The company submitted its 32nd Annual Report and AGM notice for FY 2025-26. The meeting is scheduled for September 29, 2026.
Advik Laboratories Board Meeting Outcome
MPS Pharmaa Ltd announced the outcome of its board meeting, fixing the 32nd AGM date and recommending new director and auditor appointments for shareholder approval.
Advik Laboratories Board Meeting Date
MPS Pharmaa Limited has scheduled a board meeting on September 02, 2026, to consider the notice for the company's upcoming Annual General Meeting.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.